Framework Ventures IV L.P. - Oct 9, 2025 SCHEDULE 13D Report for NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value (NBY)

Filing Manager
Framework Ventures IV L.P.
Reporting Manager
Framework Ventures IV L.P.
Security
NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value
Symbol
NBY
Shares outstanding
7.19M shares
Disclosed Ownership
1.16M shares
Ownership
16.2%
Form type
SCHEDULE 13D
Date filed
10/15/2025, 08:28 PM
Date of event
Oct 9, 2025
Next filing
Oct 20, 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Framework Ventures IV L.P. 16.2% 1.16M 0 1.16M /s/ Michael Ernest Anderson Michael Ernest Anderson / Authorized Signatory 0002028474
Framework Ventures Management LLC 16.2% 1.16M 0 1.16M /s/ Michael Ernest Anderson Michael Ernest Anderson / Authorized Signatory
Framework Ventures IV GP LLC 16.2% 1.16M 0 1.16M /s/ Michael Ernest Anderson Michael Ernest Anderson / Authorized Signatory
Vance Spencer 16.2% 1.16M 0 1.16M /s/ Vance Spencer Vance Spencer
Michael Ernest Anderson 16.2% 1.16M 0 1.16M /s/ Michael Ernest Anderson Michael Ernest Anderson